So these new data from Burrill are entirely all consistent with pharma corporate VC playing an important role in the ecosystem, and that they seem to get involved in good companies that possess better than average probabilities of success.

FORBES: Want Better Odds? Get a Pharma Corporate VC to Invest

These number are consistent with decades of data that I compiled for my recent book, The Power of Passive Investing.

FORBES: Active Funds Continue to Struggle

These estimates are broadly consistent with the direct recipient reporting data available for 2010:Q1.

WHITEHOUSE: Recovery Act Fourth Quarterly Report - Executive Summary